Skip to main content
OpenTrials

Clinical trial condition

Skin Neoplasms

Explore clinical trials studying Skin Neoplasms. Study availability and eligibility vary by location and protocol.

2,111 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Skin Neoplasms trial results

Completed

Intermittent Selumetinib for Uveal Melanoma

NCT02768766

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • Columbia University Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

NCT02658890

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
Locations
  • Local Institution - 0028 Tucson, Arizona, United States
  • Local Institution - 0026 La Jolla, California, United States
  • Local Institution - 0035 Tampa, Florida, United States
  • Local Institution - 0005 Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Completed

Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma

NCT01152788

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada
  • BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
View all 19 locations
View Trial Details
Completed

Efficacy Study of IL-21 to Treat Metastatic Melanoma

NCT00336986

Conditions
Cancer, Malignant Melanoma, Melanoma, +11 more
Locations
  • Novo Nordisk Investigational Site Box Hill, Australia
  • Novo Nordisk Investigational Site East Melbourne, Australia
  • Novo Nordisk Investigational Site Heidelberg, Australia
  • Novo Nordisk Investigational Site Malvern, Australia
View Trial Details
Completed

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

NCT00053781

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada
  • Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada
  • Princess Margaret Hospital at University Health Network Toronto, Ontario, Canada
View Trial Details

Related conditions